Cross Herb Insider Trades

Insider Trading History

Track insider trading activity for Cross Herb. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Jasper Therapeutics- Warrants (24/09/2026)
Jasper Therapeutics- Warrants (24/09/2026) JSPRW
Chief Financial Officer
Holding Value $1.08k 90,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.14k 90,000 shares
$0.07
$0.01
Jasper Therapeutics
Jasper Therapeutics JSPR
Chief Financial Officer
Holding Value $44k 90,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$166k 90,000 shares
$1.84
$0.49
Jasper Therapeutics- Warrants (24/09/2026)
Jasper Therapeutics- Warrants (24/09/2026) JSPRW
Chief Financial Officer
Holding Value $1.08k 90,000 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.56k 90,000 shares
$0.10
$0.01
Jasper Therapeutics
Jasper Therapeutics JSPR
Chief Financial Officer
Holding Value $44k 90,000 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$540k 90,000 shares
$6.00
$0.49
Jasper Therapeutics
Jasper Therapeutics JSPR
Chief Financial Officer
Holding Value $24.5k 50,000 shares
Last Trade
Feb 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$275k 50,000 shares
$5.49
$0.49
Jasper Therapeutics- Warrants (24/09/2026)
Jasper Therapeutics- Warrants (24/09/2026) JSPRW
Chief Financial Officer
Holding Value $600 50,000 shares
Last Trade
Feb 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.92k 50,000 shares
$0.16
$0.01
Jasper Therapeutics- Warrants (24/09/2026)
Jasper Therapeutics- Warrants (24/09/2026) JSPRW
Chief Financial Officer
Holding Value $480 40,000 shares
Last Trade
Feb 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.2k 40,000 shares
$0.18
$0.01
Jasper Therapeutics
Jasper Therapeutics JSPR
Chief Financial Officer
Holding Value $19.6k 40,000 shares
Last Trade
Feb 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$718k 40,000 shares
$17.95
$0.49
Jasper Therapeutics- Warrants (24/09/2026)
Jasper Therapeutics- Warrants (24/09/2026) JSPRW
Chief Financial Officer
Holding Value $6.6k 550,000 shares
Last Trade
Sep 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.8k 550,000 shares
$0.06
$0.01
Jasper Therapeutics
Jasper Therapeutics JSPR
Chief Financial Officer
Holding Value $269k 550,000 shares
Last Trade
Sep 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.29M 550,000 shares
$7.80
$0.49
Apexigen- Warrants (29/07/2027)
Apexigen- Warrants (29/07/2027) APGNW
Director
Holding Value $0 0 shares
Last Trade
Aug 23, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.5k 134,084 shares
$0.03
$0.03
Apexigen
Apexigen APGN
Director
Holding Value $0 0 shares
Last Trade
Aug 23, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$51.6k 134,084 shares
$0.39
$0.39
Atreca
Atreca BCEL
Chief Financial Officer
Holding Value $6.55k 72,817 shares
Last Trade
Aug 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.21k 5,487 shares
$0.95
$0.09
Atreca
Atreca BCEL
Chief Financial Officer
Holding Value $15.8k 175,000 shares
Last Trade
Feb 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$261k 175,000 shares
$1.49
$0.09
Apexigen
Apexigen APGN
Director
Holding Value $38.5k 100,000 shares
Last Trade
Sep 29, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$265k 100,000 shares
$2.65
$0.39
Apexigen- Warrants (29/07/2027)
Apexigen- Warrants (29/07/2027) APGNW
Director
Holding Value $2.61k 100,000 shares
Last Trade
Sep 29, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19k 100,000 shares
$0.19
$0.03
Apexigen- Warrants (29/07/2027)
Apexigen- Warrants (29/07/2027) APGNW
Director
Holding Value $0 0 shares
Last Trade
Jul 29, 2022 Sale
No data
No data
$0.03
Apexigen
Apexigen APGN
Director
Holding Value $0 0 shares
Last Trade
Jul 29, 2022 Sale
No data
No data
$0.39
Atreca
Atreca BCEL
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 13, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$179k 97,000 shares
$1.84
$0.09
Atreca
Atreca BCEL
Chief Financial Officer
Holding Value $8.73k 97,000 shares
Last Trade
Jun 13, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$179k 97,000 shares
$1.84
$0.09

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up